Interleukin-13

The Cytokine Handbook

Volumn , Issue , 2003, Pages 409-429

  Grünig, Gabriele ^a   de Vries, Jan E ^b   Malefyt, Rene de Waal ^c  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b NOVARTIS RESEARCH INSTITUTE   (Austria)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33544468061     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012689663-3/50021-1     Document Type: Chapter

References (307)

1. Agarwal S., Rao A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 1998, 9:765-775.
2. Ahmed S., Ihara K., Sasaki Y., et al. Novel polymorphism in the coding region of the IL-13 receptor alpha' gene: association study with atopic asthma in the Japanese population. Exp. Clin. Immunogenet. 2000, 17:18-22.
3. Akaiwa M., Yu B., Umeshita-Suyama R., et al. Localization of human interleukin 13 receptor in non-haematopoietic cells. Cytokine 2001, 13:75-84.
4. Aman M.J., Tayebi N., Obiri N.I., et al. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J. Biol. Chem. 1996, 271:29265-29270.
5. Andersson A., Grunewald S.M., Duschl A., et al. Mouse macrophage development in the absence of the common γ chain: defining receptor complexes responsible for IL-4 and IL-13 signaling. Eur. J. Immunol. 1997, 27:1762-1768.
6. Andrew D.P., Chang M.S., McNinch J., et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 1998, 161:5027-5038.
7. Artis D., Humphreys N.E., Bancroft A.J., et al. Tumor necrosis factor alpha is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection. J. Exp. Med. 1999, 190:953-962.
8. Artis D., Potten C.S., Else K.J., et al. Trichuris muris: host intestinal epithelial cell hyperproliferation during chronic infection is regulated by interferon-gamma. Exp. Parasitol. 1999, 92:144-153.
9. Aversa G., Punnonen J., Cocks B.G., et al. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med. 1993, 178:2213-2218.
10. Bamborough P., Duncan D., Richards W.G. Predictive modelling of the 3-D structure of interleukin-13. Protein Eng. 1994, 7:1077-1082.
11. Bancroft A.J., McKenzie A.N., Grencis R.K. A critical role for IL-13 in resistance to intestinal nematode infection. J. Immunol. 1998, 160:3453-3461.
12. Bancroft A.J., Artis D., Donaldson D.D., et al. Gastrointestinal nematode expulsion in IL-4 knockout mice is IL-13 dependent. Eur. J. Immunol. 2000, 30:2083-2091.
13. Barner M., Mohrs M., Brombacher F., Kopf M. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol. 1998, 8:669-672.
14. Baumhofer J.M., Beinhauer B.G., Wang J.E., et al. Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur. J. Immunol. 1998, 28:610-615.
15. Berg D.J., Kuhn R., Rajewsky K., et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 1995, 96:2339-2347.
16. Berkman N., John M., Roesems G., et al. Interleukin 13 inhibits macrophage inflammatory protein-1 alpha production from human alveolar macrophages and monocytes. Am. J. Respir. Cell Mol. Biol. 1996, 15:382-389.
17. Bernard J., Treton D., Vermot-Desroches C., et al. Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Ralpha2 as a decoy receptor for IL13. Lab. Invest. 2001, 81:1223-1231.
18. Bessis N., Boissier M.C., Ferrara P., et al. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 1996, 26:2399-2403.
19. Blease K., Jakubzick C., Schuh J.M., et al. IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice. J. Immunol. 2001, 167:6583-6592.
20. Blease K., Jakubzick C., Westwick J., et al. Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J. Immunol. 2001, 166:5219-5224.
21. Blease K., Schuh J.M., Jakubzick C., et al. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am. J. Pathol. 2002, 160:481-490.
22. Bochner B.S., Klunk D.A., Sterbinsky S.A., et al. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol. 1995, 154:799-803.
23. Bodey K.J., Semper A.E., Redington A.E., et al. Cytokine profiles of BALT cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. Allergy 1999, 54:1083-1093.
24. Bonecchi R., Sozzani S., Stine J.T., et al. Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 1998, 92:2668-2671.
25. Bonecchi R., Facchetti F., Dusi S., et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J. Immunol. 2000, 164:3862-3869.
26. Brinkmann V., Kristofic C. TCR-stimulated naive human CD4+ 45RO-T cells develop into effector cells that secrete IL-13, IL-5, and IFN-gamma, but no IL-4, and help efficient IgE production by B cells. J. Immunol. 1995, 154:3078-3087.
27. Brown K.D., Zurawski S.M., Mosmann T.R., Zurawski G. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors and indicators of various activation processes. J. Immunol. 1989, 142:679-687.
28. Bullens D.M., Kasran A., Thielemans K., et al. CD40L-induced IL-12 production is further enhanced by the Th2 cytokines IL-4 and IL-13. Scand. J. Immunol. 2001, 53:455-463.
29. Burd P.R., Thompson W.C., Max E.E., Mills F.C. Activated mast cells produce interleukin 13. J. Exp. Med. 1995, 181:1373-1380.
30. Caput D., Laurent P., Kaghad M., et al. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J. Biol. Chem. 1996, 271:16921-16926.
31. Cash E., Minty A., Ferrara P., et al. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 1994, 153:4258-4267.
32. Ceponis P.J., Botelho F., Richards C.D., McKay D.M. Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement. J. Biol. Chem. 2000, 275:29132-29137.
33. Chabaud M., Page G., Miossec P. Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J. Immunol. 2001, 167:6015-6020.
34. Chaouchi N., Wallon C., Goujard C., et al. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 1996, 87:1022-1029.
35. Chiaramonte M.G., Donaldson D.D., Cheever A.W., Wynn T.A. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 1999, 104:777-785.
36. Chiaramonte M.G., Schopf L.R., Neben T.Y., et al. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J. Immunol. 1999, 162:920-930.
37. Chiaramonte M.G., Cheever A.W., Malley J.D., et al. Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 2001, 34:273-282.
38. Chomarat P., Rissoan M.C., Pin J.J., et al. Contribution of IL-1, CD14, and CD13 in the increased IL-6 production induced by in vitro monocyte-synoviocyte interactions. J. Immunol. 1995, 155:3645-3652.
39. Cocks B.G., de Waal Malefyt R., Galizzi J.P., et al. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int. Immunol. 1993, 5:657-663.
40. Cohn L., Homer R.J., MacLeod H., et al. Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J. Immunol. 1999, 162:6178-6183.
41. Colotta F., Re F., Muzio M., Polentarutti N., et al. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J. Biol. Chem. 1994, 269:12403-12406.
42. Colotta F., Saccani S., Giri J.G., et al. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J. Immunol. 1996, 156:2534-2541.
43. Corry D.B. IL-13 in allergy: home at last. Curr. Opin. Immunol. 1999, 11:610-614.
44. Cosentino G., Soprana E., Thienes C.P., et al. IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes. J. Immunol. 1995, 155:3145-3151.
45. Crnogorac-Jurcevic T., Efthimiou E., Capelli P., et al. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001, 20:7437-7446.
46. D'Andrea A., Ma X., Aste-Amezaga M., et al. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J. Exp. Med. 1995, 181:537-546.
47. Danahay H., Atherton H., Jones G., et al. Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 282:L226-L236.
48. Das J., Chen C.H., Yang L., et al. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2001, 2:45-50.
49. de Saint-Vis B., Fugier-Vivier I., Massacrier C., et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 1998, 160:1666-1676.
50. de Waal Malefyt R., figdor C.G., Huijbens R., et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J. Immunol. 1993, 151:6370-6381.
51. de Waal Malefyt R., Abrams J.S., Zurawski S.M., et al. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int. Immunol. 1995, 7:1405-1416.
52. Debinski W., Miner R., Leland P., et al. Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells. J. Biol. Chem. 1996, 271:22428-22433.
53. Debinski W., Obiri N.I., Pastan I., Puri R.K. A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4. J. Biol. Chem. 1995, 270:16775-16780.
54. Debinski W., Gibo D.M. Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen. Mol. Med. 2000, 6:440-449.
55. DeFife K.M., Jenney C.R., McNally A.K., et al. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J. Immunol. 1997, 158:3385-3390.
56. Defrance T., Carayon P., Billian G., et al. Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 1994, 179:135-143.
57. Del Prete G., De Carli M., Lammel R.M., et al. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 1995, 86:250-257.
58. Derocq J.M., Segui M., Poinot-Chazel C., et al. Interleukin-13 stimulates interleukin-6 production by human keratinocytes. Similarity with interleukin-4. FEBS Lett. 1994, 343:32-36.
59. Devouassoux G., Foster B., Scott L.M., et al. Frequency and characterization of antigen-specific IL-4- and IL-13-producing basophils and T cells in peripheral blood of healthy and asthmatic subjects. J. Allergy Clin. Immunol. 1999, 104:811-819.
60. Doherty T.M., Kastelein R., Menon S., et al. Modulation of murine macrophage function by IL-13. J. Immunol. 1993, 151:7151-7160.
61. Dolganov G., Bort S., Lovett M., et al. Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood 1996, 87:3316-3326.
62. Donaldson D.D., Whitters M.J., Fitz L.J., et al. the murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J. Immunol. 1998, 161:2317-2324.
63. Donaldson D.D., Elias J.A., Wills-Karp M. Interleukin-13 antagonism. New Drugs for Asthma, Allergy and COPD 2000, 260-264. Karger, Basel. T. Hansel, P. Barnes (Eds.).
64. Doucet C., Brouty-Boye D., Pottin-Clemenceau C., et al. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest. 1998, 101:2129-2139.
65. Doucet C., Jasmin C., Azzarone B. Unusual interleukin-4 and -13 signaling in human normal and tumor lung fibroblasts. Oncogene 2000, 19:5898-5905.
66. Doyle A.G., Herbein G., Montaner L.J., et al. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur. J. Immunol. 1994, 24:1441-1445.
67. Duda P.W., Schmied M.C., Cook S.L., et al. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J. Clin. Invest. 2000, 105:967-976.
68. Eisenmesser E.Z., Horita D.A., Altieri A.S., Byrd R.A. Solution structure of interleukin-13 and insights into receptor engagement. J. Mol. Biol. 2001, 310:231-241.
69. Emilie D., Zou W., Fior R., et al. Production and roles of IL-6, IL-10, and IL-13 in B-lymphocyte malignancies and in B-lymphocyte hyperactivity of HIV infection and autoimmunity. Methods 1997, 11:133-142.
70. Endo T., Ogushi F., Sone S. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-gamma. J. Immunol. 1996, 156:2240-2246.
71. Ernofsson M., Tenno T., Siegbahn A. Inhibition of tissue factor surface expression in human peripheral blood monocytes exposed to cytokines. Br. J. Haematol. 1996, 95:249-257.
72. Essayan D.M., Han W.F., Li X.M., et al. Clonal diversity of IL-4 and IL-13 expression in human allergen-specific T lymphocytes. J. Allergy Clin. Immunol. 1996, 98:1035-1044.
73. Etter H., Althaus R., Eugster H.P., et al. IL-4 and IL-13 downregulate rolling adhesion of leukocytes to IL-1 or TNF-alpha-activated endothelial cells by limiting the interval of E-selectin expression. Cytokine 1998, 10:395-403.
74. Ezernieks J., Schnarr B., Metz K., Duschl A. The human IgE germline promoter is regulated by interleukin-4, interleukin-13, interferon-alpha and interferon-gamma via an interferon-gamma-activated site and its flanking regions. Eur. J. Biochem. 1996, 240:667-673.
75. Fallon P.G., Richardson E.J., McKenzie G.J., McKenzie A.N. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 2000, 164:2585-2591.
76. Fallon P.G., Emson C.L., Smith P., McKenzie A.N. IL-13 overexpression predisposes to anaphylaxis following antigen sensitization. J. Immunol. 2001, 166:2712-2716.
77. Feng N., Schnyder B., Vonderschmitt D.J., et al. Characterization of interleukin-13 receptor in carcinoma cell lines and human blood cells and comparison with the interleukin-4 receptor. J. Recept. Signal Transduct. Res. 1995, 15:931-949.
78. Feng N., Lugli S.M., Schnyder B., et al. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. Lab. Invest. 1998, 78:591-602.
79. Finkelman F.D., Wynn T.A., Donaldson D.D., Urban J.F. The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. Curr. Opin. Immunol. 1999, 11:420-426.
80. Finkelman F.D., Urban J.F. The other side of the coin: the protective role of the Th2 cytokines. J. Allergy Clin. Immunol. 2001, 107:772-780.
81. Fior R., Vita N., Raphael M., et al. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes. Eur. Cytokine Netw. 1994, 5:593-600.
82. Fiumara P., Cabanillas F., Younes A. Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers. Blood 2001, 98:2877-2878.
83. Ford D., Sheehan C., Girasole C., et al. The human B cell response to IL-13 is dependent on cellular phenotype as well as mode of activation. J. Immunol. 1999, 163:3185-3193.
84. Ford J.G., Rennick D., Donaldson D.D., et al. IL-13 and IFN-gamma: interactions in lung inflammation. J. Immunol. 2001, 167:1769-1777.
85. Fort M.M., Cheung J., Yen D., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001, 15:985-995.
86. Foster P.S., Mould A.W., Yang M., et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 2001, 179:173-181.
87. Fraticelli P., Sironi M., Bianchi G., et al. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J. Clin. Invest. 2001, 107:1173-1181.
88. Fujisawa T., Kato Y., Atsuta J., et al. Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by Th2- and Th1-derived cytokines. J. Allergy Clin. Immunol. 2000, 105:126-133.
89. Fukushi J., Ono M., Morikawa W., et al. The activity of soluble VCAM-1 in angiogenesis stimulated by IL-4 and IL-13. J. Immunol. 2000, 165:2818-2823.
90. Gauchat J.F., Henchoz S., Mazzei G., et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993, 365:340-343.
91. Gauchat J.F., Schlagenhauf E., Feng N.P., et al. A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur. J. Immunol. 1997, 27:971-978.
92. Gibbs B.F., Haas H., Falcone F.H., et al. Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation. Eur. J. Immunol. 1996, 26:2493-2498.
93. Girard D., Paquin R., Naccache P.H., Beaulieu A.D. Effects of interleukin-13 on human neutrophil functions. J. Leukoc. Biol. 1996, 59:412-419.
94. Graber P., Gretener D., Herren S., et al. The distribution of IL-13 receptor alphal expression on B cells, T cells and monocytes and its regulation by IL-13 and IL-4. Eur. J. Immunol. 1998, 28:4286-4298.
95. Graves P.E., Kabesch M., Halonen M., et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J. Allergy Clin. Immunol. 2000, 105:506-513.
96. Grunig G., Warnock M., Wakil A.E., et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998, 282:2261-2263.
97. Guo L., Hu-Li J., Zhu J., et al. Disrupting IL13 impairs production of IL-4 specified by the linked allele. Nat. Immunol. 2001, 2:461-466.
98. Hamid Q., Naseer T., Minshall E.M., et al. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J. Allergy Clin. Immunol. 1996, 98:225-231.
99. Haque S.J., Harbor P., Tabrizi M., et al. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J. Biol. Chem. 1998, 273:33893-33896.
100. Hart P.H., Ahern M.J., Smith M.D., Finlay-Jones J.J. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin. Exp. Immunol. 1995, 99:331-337.
101. Hart P.H., Bonder C.S., Balogh J., et al. Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6. Eur. J. Immunol. 1999, 29:2087-2097.
102. He Y.W., Adkins B., Furse R.K., Malek T.R. Expression and function of the gamma c subunit of the IL-2, IL-4, and IL-7 receptors. Distinct interaction of gamma c in the IL-4 receptor. J. Immunol. 1995, 154:1596-1605.
103. Heinzmann A., Mao X.Q., Akaiwa M., et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum. Mol. Genet. 2000, 9:549-559.
104. Herbert J.M., Savi P., Laplace M.C., et al. IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett. 1993, 328:268-270.
105. Hilton D.J., Zhang J.G., Metcalf D., et al. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl Acad. Sci. USA 1996, 93:497-501.
106. Hodge M.R., Ranger A.M., Charles de la Brousse F., et al. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 1996, 4:397-405.
107. Hoeck J., Woisetschlager M. Activation of eotaxin-3/cc126 gene expression in human dermal fibroblasts is mediated by stat6. J. Immunol. 2001, 167:3216-3222.
108. Hoerauf A., Kruse S., Brattig N.W., et al. The variant Arg110Gln of human IL-13 is associated with an immunologically hyper-reactive form of onchocerciasis (sowda). Microbes Infect. 2002, 4:37-42.
109. Hoshino T., Wiltrout R.H., Young H.A. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J. Immunol. 1999, 162:5070-5077.
110. Hoshino T., Winkler-Pickett R.T., Mason A.T., et al. IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J. Immunol. 1999, 162:51-59.
111. Howard T.D., Whittaker P.A., Zaiman A.L., et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am. J. Respir. Cell Mol. Biol. 2001, 25:377-384.
112. Howard T.D., Koppelman G.H., Xu J., et al. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am. J. Hum. Genet. 2002, 70:230-236.
113. Huang S.K., Xiao H.Q., Kleine-Tebbe J., et al. IL-13 expression at the sites of allergen challenge in patients with asthma. J. Immunol. 1995, 155:2688-2694.
114. Huang S.K., Xiao H.Q., Kleine-Tebbe J., et al. IL-13 expression at the sites of allergen challenge in patients with asthma. J. Immunol. 1995, 155:2688-2694.
115. Humbert M., Durham S.R., Kimmitt P., et al. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J. Allergy Clin. Immunol. 1997, 99:657-665.
116. Husain S.R., Puri R.K. Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS - Kaposi's sarcoma xenograft. Blood 2000, 95:3506-3513.
117. Husain S.R., Joshi B.H., Puri R.K. Interleukin-13 receptor as a unique target for anti-glioblastoma therapy. Int. J. Cancer 2001, 92:168-175.
118. Ikizawa K., Kajiwara K., Izuhara K., Yanagihara Y. PKCdelta and zeta mediate IL-4/IL-13-induced germline epsilon transcription in human B cells: a putative regulation via PU.1 phosphorylation. Biochem. Biophys. Res. Commun. 2001, 288:34-41.
119. Ise T., Izumi H., Nagatani G., et al. Structural characterization of the human interleukin-13 receptor alphal gene promoter. Biochem. Biophys. Res. Commun. 1999, 265:387-394.
120. Isomaki P., Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann. Med. 1997, 29:499-507.
121. Isomaki P., Luukkainen R., Toivanen P., Punnonen J. The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum. 1996, 39:1693-1702.
122. Izuhara K., Heike T., Otsuka T., et al. Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J. Biol. Chem. 1996, 271:619-622.
123. Jacobsen S.E., Okkenhaug C., Veiby O.P., et al. Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J. Exp Med 1994, 180:75-82.
124. Jaffe J.S., Raible D.G., Post T.J., et al. Human lung mast cell activation leads to IL-13 mRNA expression and protein release. Am. J. Respir. Cell Mol. Biol. 1996, 15:473-481.
125. Jaffar Z., Roberts K., Pandit A., et al. B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects, in response to allergen stimulation. Am. J. Respir. Cell Mol. Biol. 1999, 20:153-162.
126. Jankovic D., Kullberg M.C., Noben-Trauth N., et al. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J. Immunol. 1999, 163:337-342.
127. Johansson B., Ingvarsson S., Bjorck P., Borrebaeck C.A. Human interdigitating dendritic cells induce isotype switching and IL-13-dependent IgM production in CD40-activated naive B cells. J. Immunol. 2000, 164:1847-1854.
128. John M., Hirst S.J., Jose P.J., et al. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. J. Immunol. 1997, 158:1841-1847.
129. Jung T., Wijdenes J., Neumann C., et al. Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12. Eur. J. Immunol. 1996, 26:571-577.
130. Kapp U., Yeh W.C., Patterson B., et al. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J. Exp. Med. 1999, 189:1939-1946.
131. Katz Y., Stav D., Barr J., Passwell J.H. IL-13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)-stimulated fibroblasts. Clin. Exp. Immunol. 1995, 101:150-156.
132. Kawakami K., Kawakami M., Snoy P.J., et al. In ivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice. J. Exp. Med. 2001, 194:1743-1754.
133. Kawakami K., Taguchi J., Murata T., Puri R.K. The interlerkin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood 2001, 97:2673-2679.
134. Keegan A.D., Johnston J.A., Tortolani P.J., et al. Similarities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation. Proc. Natl Acad. Sci. USA 1995, 92:7681-7685.
135. Kelly B.L., Locksley R.M. Coordinate regulation of the IL-4, IL-13, and IL-5 cytokine cluster in Th2 clones revealed by allelic expression patterns. J. Immunol. 2000, 165:2982-2986.
136. Khan W.I., Blennerhasset P., Ma C., et al. Stat6 dependent goblet cell hyperplasia during intestinal nematode infection. Parasite Immunol. 2001, 23:39-42.
137. Khan W.I., Vallance B.A., Blennerhassett P.A., et al. Critical role for signal transducer and activator of transcription factor 6 in mediating intestinal muscle hyper-contractility and worm expulsion in Trichinella spiralis-infected mice. Infect. Immun. 2001, 69:838-844.
138. Kishikawa H., Sun J., Choi A., et al. The cell type-specific expression of the murine il-13 gene is regulated by gata-3. J. Immunol. 2001, 167:4414-4420.
139. Kobayashi H., Okayama Y., Ishizuka T., et al. Production of IL-13 by human lung mast cells in response to Fcepsilon receptor cross-linkage. Clin. Exp. Allergy 1998, 28:1219-1227.
140. Kolios G., Robertson D.A., Jordan N.J., et al. Interleukin-8 production by the human colon epithelial cell line HT-29: modulation by interleukin-13. Br. J. Pharmacol. 1996, 119:351-359.
141. Koning H., Neijens H.J., Baert M.R., et al. T cell subsets and cytokines in allergic and non-allergic children. I. Analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production. Cytokine 1997, 9:416-426.
142. Kotowicz K., Dixon G.L., Klein N.J., et al. Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunology 2000, 100:441-448.
143. Kotsimbos T.C., Ernst P., Hamid Q.A. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc. Assoc. Am. Physicians 1996, 108:368-373.
144. Kraft M., Lewis C., Pham D., Chu H.W. IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma. J. Allergy Clin. Immunol. 2001, 107:602-606.
145. Kricek F., Ruf C., Zunic M., et al. Induction in mice of serum IgE levels after treatment with anti-mouse IgD antibodies is preceded by differential modulation of tissue cytokine gene transcription. Eur. J. Immunol. 1995, 25:936-941.
146. Kroegel C., Julius P., Matthys H., et al. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts. Eur. Respir. J. 1996, 9:899-904.
147. Krug N., Erpenbeck V.J., Balke K., et al. Cytokine profile of bronchoalveolar lavage-derived CD4(+), CD8(+), and gammadelta T cells in people with asthma after segmental allergen challenge. Am. J. Respir. Cell Mol. Biol. 2001, 25:125-131.
148. Kucharzik T., Lugering N., Weigelt H., et al. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10. Clin. Exp. Immunol. 1996, 104:483-490.
149. Kucharzik T., Lugering N., Adolf M., et al. Synergistic effect of immunoregulatory cytokines on, peripheral blood monocytes from patients with inflammatory bowel disease. Dig. Dis. Sci. 1997, 42:805-812.
150. Kung T.T., Luo B., Crawley Y., et al. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am. J. Respir. Cell Mol. Biol. 2001, 25:600-605.
151. Lacy D.A., Wang Z.E., Symula D.J., et al. Faithful expression of the human 5q31 cytokine cluster in transgenic mice. J. Immunol. 2000, 164:4569-4574.
152. Lai Y.H., Mosmann T.R. Mouse IL-13 enhances antibody production in vivo and acts directly on B cells in vitro to increase survival and hence antibody production. J. Immunol. 1999, 162:78-87.
153. Lai Y.H., Heslan J.M., Poppema S., et al. Continuous administration of Il-13 to mice induces extramedullary hemopoiesis and monocytosis. J. Immunol. 1996, 156:3166-3173.
154. Laoukili J., Perret E., Willems T., et al. IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J. Clin. Invest. 2001, 108:1817-1824.
155. Laporte J.C., Moore P.E., Baraldo S., et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 2001, 164:141-148.
156. Lee C.G., Homer R.J., Zhu Z., et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 2001, 194:809-821.
157. Lee J.H., Kaminski N., Dolganov G., et al. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am. J. Respir. Cell Mol. Biol. 2001, 25:474-485.
158. Lefort S., Vita N., Reeb R., et al. IL-13 and IL-4 share signal transduction elements as well as receptor components in TF-1 cells. FEBS Lett. 1995, 366:122-126.
159. Lentsch A.B., Czermak B.J., Jordan J.A., Ward P.A. Regulation of acute lung inflammatory injury by endogenous IL-13. J. Immunol. 1999, 162:1071-1076.
160. Leung D.Y. Atopic dermatitis: immunobiology and treatment with immune modulators. Clin. Exp. Immunol. 1997, 107(Suppl. 1):25-30.
161. Leung T.F., Tang N.L., Chan I.H., et al. A polymorphism in the coding region of interleukin-13 gene is associated with atopy but not asthma in Chinese children. Clin. Exp. Allergy 2001, 31:1515-1521.
162. Levy F., Kristofic C., Heusser C., Brinkmann V. Role of IL-13 in CD4 T cell-dependent IgE production in atopy. Int. Arch. Allergy Immunol. 1997, 112:49-58.
163. Li H., Sim T.C., Alam R. IL-13 released by and localized in human basophils. J. Immunol. 1996, 156:4833-4838.
164. Li L., Xia Y., Nguyen A., et al. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 1999, 162:2477-2487.
165. Liu X., Nickel R., Beyer K., et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J. Allergy Clin. Immunol. 2000, 106:167-170.
166. Loots G.G., Locksley R.M., Blankespoor C.M., et al. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 2000, 288:136-140.
167. Lukacs N.W., Hogaboam C., Chensue S.W., et al. Type 1/type 2 cytokine paradigm and the progression of pulmonary fibrosis. Chest 2001, 120:5S-8S.
168. Lukacs N.W., Tekkanat K.K., Berlin A., et al. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J. Immunol. 2001, 167:1060-1065.
169. Luttmann W., Knoechel B., Foerster M., et al. Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. J. Immunol. 1996, 157:1678-1683.
170. Magazin M., Guillemot J.C., Vita N., Ferrara P. Interleukin-13 is a monocyte chemoattractant. Eur. Cytokine Netw. 1994, 5:397-400.
171. Marfaing-Koka A., Devergne O., Gorgone G., et al. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J. Immunol. 1995, 154:1870-1878.
172. Marietta E.V., Chen Y., Weis J.H. Modulation of expression of the anti-inflammatory cytokines interleukin-13 and interleukin-10 by interleukin-3. Eur. J. Immunol. 1996, 26:49-56.
173. Matsukawa A., Hogaboam C.M., Lukacs N.W., et al. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J. Immunol. 2000, 164:2738-2744.
174. Mattes J., Yang M., Siqueira A., et al. IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. J. Immunol. 2001, 167:1683-1692.
175. Matthews D.J., Clark P.A., Herbert J., et al. Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immuno-deficient B cells to IL-2, IL-4, IL-13, and IL-15. Blood 1995, 85:38-42.
176. Matthews D.J., Hibbert L., Friedrich K., et al. X-SCID B cell responses to interleukin-4 and interleukin-13 are mediated by a receptor complex that includes the interleukin-4 receptor alpha chain (p140) but not the gamma c chain. Eur. J. Immunol. 1997, 27:116-121.
177. Matthews D.J., Emson C.L., McKenzie G.J., et al. IL-13 is a susceptibility factor for Leishmania major infection. J. Immunol. 2000, 164:1458-1462.
178. McKenzie A.N. Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13. Pharmacol. Ther. 2000, 88:143-151.
179. McKenzie A.N., Li X., Largaespada D.A., et al. Structural comparison and chromasomal localization of the human and mouse IL-13 genes. J. Immunol. 1993, 150:5436-5444.
180. McKenzie A.N., Culpepper J.A., de Waal Malefyt R., et al. Interleukin-13, a T cell derived cytokine that regulates human monocyte and B cell function. Proc. Natl. Acad. Sci. USA 1993, 150:3735-3739.
181. McKenzie G.J., Bancroft A., Grencis R.K., McKenzie A.N. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr. Biol. 1998, 8:339-342.
182. McKenzie G.J., Emson C.L., Bell S.E., et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 1998, 9:423-432.
183. McMillan S.J., Bishop B., Townsend M.J., et al. The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J. Exp. Med. 2002, 195:51-57.
184. Miadonna A., Gibelli S., Lorini M., et al. Expression of cytokine mRNA in bronchoalveolar lavage cells from atopic asthmatic before late antigen-induced reaction. Lung 1997, 175:195-209.
185. Michel G., Ried C., Beetz A. IL-6 is a potent inducer of IL-13 mRNA in normal human keratinocytes. J. Invest. Dermatol. 1994, 103:433.
186. Miloux B., Laurent P., Bonnin O., et al. Cloning of the human IL-13R alpha 1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett. 1997, 401:163-166.
187. Minty A., Chalon P., Derocq J.M., et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993, 362:248-250.
188. Minty A., Chalon P., Guillemot J.C., et al. Molecular cloning of the MCP-3 chemokine gene and regulation of its expression. Eur. Cytokine Netw. 1993, 4:99-110.
189. Miyatake S., Arai N., Arai K. Chromatin remodeling and T helper subset differentiation. IUBMB Life 2000, 49:473-478.
190. Morgan J.G., Dolganov G.M., Robbins S.E., Paul W. The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. Nucleic Acids Res. 1992, 20:5173-5179.
191. Morita Y., Yamamura M., Kawashima M., et al. Differential in vitro effects of IL-4, IL-10, and IL-13 on proinflammatory cytokine production and fibroblast proliferation in rheumatoid synovium. Rheumatol. Int. 2001, 20:49-54.
192. Morse B., Sypek J.P., Donaldson D.D., et al. Effects of IL-13 on airway responses in the guinea pig. Am. J. Physiol. Lung Cell Mol. Physiol. 2002, 282:L44-L49.
193. Moy F.J., Diblasio E., Wilhelm J., Powers R. Solution structure of human IL-13 and implication for receptor binding. J. Mol. Biol. 2001, 310:219-230.
194. Muchamuel T., Menon S., Pisacane P., et al. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. J. Immunol. 1997, 158:2898-2903.
195. Mulligan M.S., Warner R.L., Foreback J.L., et al. Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune, complex-induced lung injury: role of endogenous IL-12. J. Immunol. 1997, 159:3483-3489.
196. Murata T., Noguchi P.D., Puri R.K. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. J. Immunol. 1996, 156:2972-2978.
197. Murata T., Obiri N.I., Puri R.K. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction. Int. J. Cancer 1997, 70:230-240.
198. Murata T., Husain S.R., Mohri H., Puri R.K. Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway. Int. Immunol. 1998, 10:1103-1110.
199. Murata T., Obiri N.I., Puri R.K. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors (review). Int. J. Mol. Med. 1998, 1:551-557.
200. Musso T., Varesio L., Zhang X., et al. IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes. J. Exp. Med. 1994, 180:2383-2388.
201. Muzio M., Re F., Sironi M., et al. Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells. Blood 1994, 83:1738-1743.
202. Nakamura Y., Azuma M., Okano Y., et al. Upregulatory effects of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte/macrophage colony-stimulating factor production by human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 1996, 15:680-687.
203. Naseer T., Minshall E.M., Leung D.Y., et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am. J. Respir. Crit. Care Med. 1997, 155:845-851.
204. Nash K.T., Thompson J.P., Debinski W. Molecular targeting of malignant gliomas with novel multiply-mutated interleukin-13-based cytotoxins. Crit. Rev. Oncol. Hematol. 2001, 39:87-98.
205. Nassar G.M., Morrow J.D., Roberts L.J.D., et al. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J. Biol. Chem. 1994, 269:27631-27634.
206. Nielsen M., Nissen M.H., Gerwien J., et al. Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3. Blood 2002, 99:973-977.
207. Nilsson G., Nilsson K. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. Eur. J. Immunol. 1995, 25:870-873.
208. Noben-Trauth N., Kropf P., Muller I. Susceptibility to Leishmania major infection in interleukin-4 deficient mice. Science 1996, 271:987-990.
209. Obiri N.I., Debinski W., Leonard W.J., Puri R.K. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15. J. Biol. Chem. 1995, 270:8797-8804.
210. Obiri N.I., Leland P., Murata T., et al. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J. Immunol. 1997, 158:756-764.
211. Ogata H., Ford D., Kouttab N., et al. Regulation of interleukin-13 receptor constituents on mature human B lymphocytes. J. Biol. Chem. 1998, 273:9864-9871.
212. Oldfield W.L., Kay A.B., Larche M. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J. Immunol. 2001, 167:1734-1739.
213. Onoe Y., Miyaura C., Kaminakayashiki T., et al. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J. Immunol. 1996, 156:758-764.
214. Osawa M., Miyoshi S., Copeland N.G., et al. Characterization of the mouse interleukin-13 receptor alpha1 gene. Immunogenetics 2000, 51:974-981.
215. Oshima Y., Puri R.K. Characterization of a powerful high affinity antagonist that inhibits biological activities of human interleukin-13. J. Biol. Chem. 2001, 276:15185-15191.
216. Oshima Y., Puri R.K. Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist. Cell Immunol. 2001, 211:37-42.
217. Palmer-Crocker R.L., Hughes C.C., Pober J.S. IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain. J. Clin. Invest. 1996, 98:604-609.
218. Pantelidis P., Jones M.G., Welsh K.I., et al. Identification of four novel interleukin-13 gene polymorphisms. Genes Immun. 2000, 1:341-345.
219. Pawankar R.U., Okuda M., Hasegawa S., et al. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am. J. Respir. Crit. Care Med. 1995, 152:2059-2067.
220. Pawankar R., Okuda M., Yssel H., et al. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 1997, 99:1492-1499.
221. Pearlman E., Lass J.H., Bardenstein D.S., et al. Onchocerca volvulus-mediated keratitis: cytokine production by IL-4-deficient mice. Exp. Parasitol. 1996, 84:274-281.
222. Piemonti L., Bernasconi S., Luini W., et al. IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. Eur. Cytokine Netw. 1995, 6:245-252.
223. Pope S.M., Brandt E.B., Mishra A., et al. IL-13 induces eosinophil recruitment into the lung by an IL-5-and eotaxin-dependent mechanism. J. Allergy Clin. Immunol. 2001, 108:594-601.
224. Poudrier J., Graber P., Herren S., et al. A novel monoclonal antibody, C41, reveals IL-13Ralphal expression by murine germinal center B cells and follicular dendritic cells. Eur. J. Immunol. 2000, 30:3157-3164.
225. Prieto J., Lensmar C., Roquet A., et al. Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir. Med. 2000, 94:806-814.
226. Punnonen J., de Vries J.E. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. J. Immunol. 1994, 152:1094-1102.
227. Punnonen J., Aversa G., Cocks B.G., et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgG synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 1993, 90:3730-3734.
228. Punnonen J., Cocks B.G., de Vries J.E. IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of function IL-4 and IL-13 receptors during B cell ontogeny. J. Immunol. 1995, 155:4248-4254.
229. Punnonen J., Yssel H., de Vries J.E. The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells. J. Allergy Clin. Immunol. 1997, 100:792-801.
230. Ray A., Cohn L. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J. Clin. Invest. 1999, 104:985-993.
231. Relic B., Guicheux J., Mezin F., et al. Il-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. J. Immunol. 2001, 166:2775-2782.
232. Renard N., Duvert V., Banchereau J., Saeland S. Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors. Blood 1994, 84:2253-2260.
233. Richter A., Puddicombe S.M., Lordan J.L., et al. The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am. J. Respir. Cell Mol. Biol. 2001, 25:385-391.
234. Riemann D., Kehlen A., Langner J. Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13. Clin. Exp. Immunol. 1995, 100:277-283.
235. Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 2000, 85:9-18. quiz 18, 21.
236. Romani N., Reider D., Heuer M., et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 1996, 196:137-151.
237. Sakamoto O., Hashiyama M., Minty A., et al. Interleukin-13 selectively suppresses the growth of human macrophage progenitors at the late stage. Blood 1995, 85:3487-3493.
238. Saura M., Martinez-Dalmau R., Minty A., et al. Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells. Biochem. J. 1996, 313:641-646.
239. Schnyder B., Lugli S., Feng N., et al. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Blood 1996, 87:4286-4295.
240. Scola M.P., Thompson S.D., Brunner H.I., et al. Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J. Rheumatol. 2002, 29:369-378.
241. Sebire G., Delfraissy J.F., Demotes-Mainard J., et al. Interleukin-13 and interleukin-4 act as interleukin-6 inducers in human microglial cells. Cytokine 1996, 8:636.
242. Seitz M., Loetscher P., Dewald B., et al. Opposite effects of interleukin-13 and interleukin-12 on the release of inflammatory cytokines, cytokine inhibitors and prostaglandin E from synovial fibroblasts and blood mononuclear cells. Eur. J. Immunol. 1996, 26:2198-2202.
243. Shea-Donohue T., Sullivan C., Finkelman F.D., et al. The role of IL-4 in Heligmosomoides polygyrus-induced alterations in murine intestinal epithelial cell function. J. Immunol. 2001, 167:2234-2239.
244. Shim J.J., Dabbagh K., Ueki I.F., et al. IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am. J. Physiol. Lung Cell Mol. Physiol. 2001, 280:L134-L140.
245. Shinkai A., Yoshisue H., Koike M., et al. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J. Immunol. 1999, 163:1602-1610.
246. Singer M., Lefort J., Vargaftig B.B. Granulocyte depletion and dexamethasone differentially modulate airways hyperreactivity, inflammation, mucus accumulation, and secretion induced by rmIL-13 or antigen. Am. J. Respir. Cell Mol. Biol. 2002, 26:74-84.
247. Sironi M., Sciacca F.L., Matteucci C., et al. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 1994, 84:1913-1921.
248. Skinnider B.F., Elia A.J., Gasconye R.D., et al. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2001, 97:250-255.
249. Skinnider B.F., Elia A.J., Gascoyne R.D., et al. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2002, 99:618-626.
250. Smerz-Bertling C., Duschl A. Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J. Biol. Chem. 1995, 270:966-970.
251. Smirnov D.V., Smirnova M.G., Korobko V.G., Frolova E.I. Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. Gene 1995, 155:277-281.
252. Sornasse T., Larenas P.V., Davis K.A., et al. Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J. Exp. Med. 1996, 184:473-483.
253. Sozzani P., Cambon C., Vita N., et al. Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes. Role of calcium and cyclic AMP. J. Biol. Chem. 1995, 270:5084-5088.
254. Spahn J.D., Szefler S.J., Surs W., et al. A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity. J. Immunol. 1996, 157:2654-2659.
255. Striz I., Mio T., Adachi Y., et al. IL-4 and IL-13 stimulate human bronchial epithelial cells to release IL-8. Inflammation 1999, 23:545-555.
256. Sun X.J., Wang L.M., Zhang Y., et al. Role of IRS-2 in insulin and cytokine signalling. Nature 1995, 377:173-177.
257. Takeda K., Kamanaka M., Tanaka T., et al. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J. Immunol. 1996, 157:3220-3222.
258. Takemoto N., Kamogawa Y., Jun Lee H., et al. Cutting edge: chromatin remodeling at the IL-4/IL-13 intergenic regulatory region for Th2-specific cytokine gene cluster. J. Immunol. 2000, 165:6687-6691.
259. Tang L., Boroughs K.L., Morales T., et al. Recombinant canine IL-13 receptor alpha2-Fc fusion protein inhibits canine allergen-specific-IgE production in vitro by peripheral blood mononuclear cells from allergic dogs. Vet. Immunol. Immunopathol. 2001, 83:115-122.
260. Tekkanat K.K., Maassab H.F., Cho D.S., et al. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J. Immunol. 2001, 166:3542-3548.
261. Temann U.A., Ray P., Flavell R.A. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 2002, 109:29-39.
262. Tengvall Linder M., Johansson C., Zargari A., et al. Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatitis and characterization of their cytokine profiles. Clin. Exp. Allergy 1996, 26:1286-1297.
263. Terabe M., Matsui S., Noben-Trauth N., et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 2000, 1:515-520.
264. Teraki Y., Hotta T., Shiohara T. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells. J. Invest. Dermatol. 2001, 117:1097-1102.
265. Theofilopoulos A.N., Koundouris S., Kono D.H., Lawson B.R. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res. 2001, 3:136-141.
266. Thivierge M., Stankova J., Rola-Pleszczynski M. Il-13 and il-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J. Immunol. 2001, 167:2855-2860.
267. Tomkinson A., Duez C., Cieslewicz G., et al. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J. Immunol. 2001, 166:5792-5800.
268. Tony H.P., Shen B.J., Reusch P., Sebald W. Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells B-cells with high efficiency. Eur. J. Biochem. 1994, 225:659-665.
269. Tsarbopoulos A., Varnerin J., Cannon-Carlson S., et al. Mass spectrometric mapping of disulfide bonds in recombinant human interleukin-13. J. Mass Spectrom. 2000, 35:446-453.
270. Urban J., Fang H., Liu Q., et al. IL-13-mediated worm expulsion is B7 independent and IFN-gamma sensitive. J. Immunol. 2000, 164:4250-4256.
271. Urban J.F., Noben-Trauth N., Donaldson D.D., et al. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 1998, 8:255-264.
272. Urban J.F., Schopf L., Morris S.C., et al. Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism. J. Immunol. 2000, 164:2046-2052.
273. Urban J.F., Noben-Trauth N., Schopf L., et al. Cutting edge: IL-4 receptor expression by non-bone marrow-derived cells is required to expel gastrointestinal nematode parasites. J. Immunol. 2001, 167:6078-6081.
274. Van der Pouw Kraan T.C., Van der Zee J.S., Boeije L.C., et al. The role of IL-13 in IgE synthesis by allergic asthma patients. Clin. Exp. Immunol. 1998, 111:129-135.
275. van der Pouw Kraan T.C., van Veen A., Boeije L.C., et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun. 1999, 1:61-65.
276. Vannier E., de Waal Malefyt R., Salazar-Montes A., et al. Interleukin-13 (IL-13) induces IL-1 receptor antagonist gene expression and protein synthesis in peripheral blood mononuclear cells: inhibition by an IL-4 mutant protein. Blood 1996, 87:3307-3315.
277. Vasse M., Paysant I., Soria J., et al. Down-regulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13. Br. J. Haematol. 1996, 93:955-961.
278. Venkayya R., Lam M., Willkom M., et al. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am. J. Respir. Cell Mol. Biol. 2002, 26:202-208.
279. von der Weid T., Kopf M., Kohler G., Langhorne J. The immune response to plasmodium chabaudi malaria in interleukin-4 deficient mice. Eur. J. Immunol. 1994, 24:2285-2293.
280. Walter D.M., McIntire J.J., Berry G., et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 2001, 167:4668-4675.
281. Wang J., Guan E., Roderiquez G., et al. Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages. J. Biol. Chem. 2001, 19:19.
282. Wang L.M., Michieli P., Lie W.R., et al. The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction. Blood 1995, 86:4218-4227.
283. Watson M.L., White A.M., Campbell E.M., et al. Anti-inflammatory actions of interleukin-13: suppression of tumor necrosis factor-alpha and antigen-induced leukocyte accumulation in the guinea pig lung. Am. J. Respir. Cell Mol. Biol. 1999, 20:1007-1012.
284. Webb D.C., McKenzie A.N., Foster P.S. Expression of the Ym2 lectin-binding protein is dependent on interleulin (IL)-4 and IL-13 signal transduction: identification of a novel allergy-associated protein. J. Biol. Chem. 2001, 276:41969-41976.
285. Weiss G., Bogdan C., Hentze M.W. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J. Immunol. 1997, 158:420-425.
286. Welham M.J., Learmonth L., Bone H., Schrader J.W. Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J. Biol. Chem. 1995, 270:12286-12296.
287. Wery-Zennaro S., Letourneur M., David M., et al. Binding of IL-4 to the IL-13Ralpha(1)/IL-4Ralpha receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation. FEBS Lett. 1999, 464:91-96.
288. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 1999, 17:255-281.
289. Wills-Karp M., Luyimbazi J., Xu X., et al. Interleukin-13: central mediator of allergic asthma. Science 1998, 282:2258-2261.
290. Woltmann G., McNulty C.A., Dewson G., et al. Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. Blood 2000, 95:3146-3152.
291. Woods J.M., Katschke K.J., Tokuhira M., et al. Reduction of inflammatory cytokines and prostaglandin E2 by IL-13 gene therapy in rheumatoid arthritis synovium. J. Immunol. 2000, 165:2755-2763.
292. Wright K., Ward S.G., Kolios G., Westwick J. Activation of phosphatidylinositol 3-kinase by interleukin-13: an inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J. Biol. Chem. 1997, 272:12626-12633.
293. Xi X., Schlegel N., Caen J.P., et al. Differential effects of recombinant human interleukin-13 on the in vitro growth of human haemopoietic progenitor cells. Br. J. Haematol. 1995, 90:921-927.
294. Yamada T., Sato A., Komiya I., et al. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease. J. Clin. Endocrinol. Metab. 2000, 85:2775-2778.
295. Yanagawa H., Sone S., Haku T., et al. Contrasting effect of interleukin-13 on interleukin-1 receptor antagonist and proinflammatory cytokine production by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 1995, 12:71-76.
296. Yang M., Hogan S.P., Henry P.J., et al. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin. Am. J. Respir. Cell Mol. Biol. 2001, 25:522-530.
297. Yano S., Yanagawa H., Nishioka Y., et al. T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages. J. Immunol. 1996, 157:2660-2665.
298. Ying S., Meng Q., Barata L.T., et al. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Immunol. 1997, 158:5050-5057.
299. Young D.A., Lowe L.D., Booth S.S., et al. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J. Immunol. 2000, 164:3563-3572.
300. Zaccone P., Phillips J., Conget I., et al. Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes 1999, 48:1522-1528.
301. Zhang D.H., Yang L., Cohn L., et al. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 1999, 11:473-482.
302. Zheng T., Zhu Z., Wang Z., et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J. Clin. Invest. 2000, 106:1081-1093.
303. Zhu Z., Homer R.J., Wang Z., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 1999, 103:779-788.
304. Zuegg J., Webb D., Foster P., Casarotto M. Structural model of humal IL-13 defines the spatial interactions with the IL-13Ralpha/IL-4Ralpha receptor. Immunol. Cell Biol. 2001, 79:332-339.
305. Zurawski G., de Vries J.E. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 1994, 15:19-26.
306. Zurawski S.M., Vega F., Huyghe B., Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 1993, 12:2663-2670.
307. Zurawski S.M., Chomarat P., Djossou O., et al. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J. Biol. Chem. 1995, 270:13869-13878.